Finding a rhyme and reason to CRISPR-Cas9’s mutations: Investigators predict CRISPR-Cas9 gene disruptions with accuracy, experimentally confirm findings in disease models

Since the early days of CRISPR-Cas9, researchers have known that this gene editing technology is excellent for breaking things. With

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study: Novel coordination of thyroid hormone with zinc promotes slow release of active hormone to supplement standard therapy

A new “metal-coordinated” drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10

Why randomized trials for proton therapy are difficult to complete (and what we can do about it): Experts lay out strategies to tackle key barriers in proton research

Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new therapies with